Outcomes and risk analysis after tricuspid valve surgery for non-Ebstein 2-ventricle congenital tricuspid valve diseasesCentral MessagePerspective by David Blitzer, MD, Ismail Bouhout, MD, Eliana Al Haddad, MD, Matthew Lewis, MD, Kanwal Farooqi, MD, Amee Shah, MD, Noa Zemer-Wassercug, MD, Harsimran Singh, MD, Brett Anderson, MD, Emile Bacha, MD, David Kalfa, MD, PhD

Get full text